Saint Simeon Marketing and Investments
2
16M
2
1
- Areas of investment
Summary
The venture was found in Asia in Philippines.
Among the various public portfolio startups of the fund, we may underline Ikonisys Among the most successful fund investment fields, there are Health Care, Biotechnology. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2007. The fund is constantly included in less than 2 investment rounds annually.
The typical case for the fund is to invest in rounds with 3 participants. Despite the Saint Simeon Marketing and Investments, startups are often financed by WGI Group, Trevi Health Ventures, New Science Ventures. The meaningful sponsors for the fund in investment in the same round are Palisade Capital Management, New Science Ventures, Lakeview Capital Management.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 1
- Investments by industry
- Biotechnology (2)
- Health Care (1)
- Health Diagnostics (1)
- Investments by region
-
- United States (2)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Group Appearance index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Carigent Therapeutics | 11 Dec 2007 | Biotechnology | Early Stage Venture | 2M | United States, Connecticut, New Haven |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.